Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: A EULAR extension of STROBE guidelines based on experience from biologics registries

Jakub Zavada, William G. Dixon, Johan Askling

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)628
    JournalAnnals of the rheumatic diseases
    Volume73
    Issue number3
    DOIs
    Publication statusPublished - 1 Mar 2014

    Keywords

    • DMARDs (biologic)
    • DMARDs (synthetic)
    • Epidemiology

    Cite this